Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Szubert

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
The Lancet. HIV|April 15, 2018
Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trialJane Mallewa, Alexander J Szubert, Peter Mugyenyi, et al.
Plos Medicine|December 5, 2018
Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trialCissy Kityo, Alexander J Szubert, Abraham Siika, et al.
Science Translational Medicine|April 5, 2019
Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activationClaire D Bourke, Ethan K Gough, Godfrey Pimundu, et al.
Eclinicalmedicine|January 23, 2023
COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2Alex J Szubert, Katrina M Pollock, Hannah M Cheeseman, et al.
Eclinicalmedicine|January 19, 2022
Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trialKatrina M Pollock, Hannah M Cheeseman, Alexander J Szubert, et al.
The New England Journal of Medicine|May 14, 2025
Second-Line Antiretroviral Therapy for Children Living with HIV in AfricaVictor Musiime, Mutsa Bwakura-Dangarembizi, Alexander J Szubert, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
The Lancet. HIV|April 15, 2018
Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trialJane Mallewa, Alexander J Szubert, Peter Mugyenyi, et al.
Plos Medicine|December 5, 2018
Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trialCissy Kityo, Alexander J Szubert, Abraham Siika, et al.
Science Translational Medicine|April 5, 2019
Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activationClaire D Bourke, Ethan K Gough, Godfrey Pimundu, et al.
Eclinicalmedicine|January 23, 2023
COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2Alex J Szubert, Katrina M Pollock, Hannah M Cheeseman, et al.
Eclinicalmedicine|January 19, 2022
Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trialKatrina M Pollock, Hannah M Cheeseman, Alexander J Szubert, et al.
The New England Journal of Medicine|May 14, 2025
Second-Line Antiretroviral Therapy for Children Living with HIV in AfricaVictor Musiime, Mutsa Bwakura-Dangarembizi, Alexander J Szubert, et al.
Pageof 5